Diclofenac Sodium SR Pellets Manufacturer in India

Swapnroop Pharma · WHO-GMP Certified · +91 87670 62101

Diclofenac Sodium SR Pellets (CAS No: 15307-79-6)
Pharmaceutical-Grade Sustained Release Pellets for Oral Dosage Forms

Diclofenac Sodium SR Pellets are pharmaceutical-grade sustained-release multiparticulate pellets containing Diclofenac Sodium, designed for controlled-release oral dosage-form applications. These pellets are suitable for pharmaceutical formulation development, capsule filling and other multiparticulate oral dosage forms requiring a sustained drug-release profile. Diclofenac Sodium has the molecular formula C₁₄H₁₀Cl₂NNaO₂ and a molecular weight of approximately 318.1 g/mol (source: PubChem).

Diclofenac Sodium sustained-release pellets can be manufactured using drug-layering and functional polymer-coating technologies to achieve the required release characteristics. Published formulation literature has described Diclofenac Sodium sustained-release pellets/beads using drug coating followed by a rate-controlling polymer coat and evaluation of the resulting in-vitro drug-release profile.

Key Features

  • Diclofenac Sodium sustained-release multiparticulate formulation
  • Designed for controlled and sustained drug-release applications
  • Suitable for pharmaceutical capsule filling and oral dosage-form development
  • Flexible formulation platform for defined drug loading and dissolution requirements
  • Suitable for modified-release pharmaceutical formulations
  • Product-specific pellet size, drug loading and release characteristics
  • Appropriate for bulk pharmaceutical formulation applications

Applications

  • Hard gelatin capsule filling for sustained-release oral dosage forms
  • Multiparticulate oral dosage-form manufacturing
  • Modified-release pharmaceutical formulations
  • Sustained-release capsule formulations for musculoskeletal pain, osteoarthritis and rheumatoid arthritis indications
  • Pharmaceutical formulation development
  • Drug-loaded pellet applications
  • Bulk pharmaceutical pellet supply
  • Oral solid dosage-form development

Why Choose Diclofenac Sodium SR Pellets?

  • Sustained-release multiparticulate platform for Diclofenac Sodium
  • Designed for controlled drug-release formulation requirements
  • Suitable for capsule-based multiparticulate dosage forms
  • Flexible drug loading and release-profile options, subject to product specification
  • Suitable for pharmaceutical formulation and development applications
  • Quality evaluation can include identification, assay/drug content, related substances, moisture and dissolution testing
  • Available formulation characteristics can be established according to customer and product requirements

Packaging & Supply
Diclofenac Sodium SR Pellets can be supplied in suitable pharmaceutical packaging for formulation development and bulk manufacturing applications. Packaging configuration, drug loading, pellet characteristics, release profile, quantity and storage requirements should be confirmed according to the applicable product specification and customer requirements.

Detailed Specifications

Parameter Specification
Appearance white to off-white crystalline powder
Identification IR & HPLC compliant
Assay (HPLC) 98.0% – 102.0%
Loss on Drying NMT 0.5%
Residue on Ignition NMT 0.1%
Total Impurities NMT 1.0%
Water Content NMT 0.5%
Get Bulk Quote via WhatsApp